![Tae-Soon Hwang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 518 $ au 31/07/2026
Tae-Soon Hwang formerly worked at THERAGEN ETEX Co., Ltd., as Co-Chief Executive Officer & Director.
Mr. Hwang received his undergraduate degree from Sungkyunkwan University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MedPacto, Inc.
 MedPacto, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops anti-cancer drugs 0 % | 31/12/2024 | 314 ( 0 % ) | 518 $ | 31/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| THERAGEN ETEX CO.,LTD. | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Sungkyunkwan University
 Sungkyunkwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
THERAGEN ETEX Co., Ltd.
 THERAGEN ETEX Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
